People with advanced HIV initiating bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) were more likely to reach CD4 cell count levels of 200 cells/mcL or ...

Despite all the research into the benefits of antiretroviral therapy (ART), clinicians are still unable to answer some of the simplest questions patients routinely ask. Among the most common: What is ...

Medically reviewed by Steffini Stalos, DO Key Takeaways CD4 T helper cells help the body fight infections by signaling other ...

Objective:To predict the effects of a new antiretroviral agent on the costs of care in a US HIV care setting. Methods: Recent data on costs of patient care by CD4 count from 2 US cohorts (the HIV ...

Long-term antiretroviral therapy helps people with HIV reduce the risk of pneumonia and shingles by strengthening the immune system. A large study shows that higher CD4 counts and sustained ART lower ...

Living with HIV means becoming fluent in a language of numbers that might seem confusing at first but actually hold the key to your health and future. Two numbers in particular – your viral load and ...

Abnormal expansion of PD-1+ T lymphocytes may be a sign of lupus nephritis onset in patients with SLE. Elevated PD-1+CD4+ T cells represent an independent risk factor for lupus nephritis (LN) and may ...

Background. Interleukin-10 (IL-10) is a potent immunoregulatory cytokine. IL-10-promoter polymorphisms have been shown to affect human immunodeficiency virus type 1 (HIV-1) clinical outcomes but the ...

September 20, 2007 — Human immunodeficiency virus (HIV)-infected patients with declining platelet counts appear to be at increased risk for HIV-associated dementia (HIV-D), a new study suggests.

Vol. 19, Supplement 3: Research from the National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2008 STEP UP High School Program with Charles Drew University ...